Literature DB >> 17549467

Advanced MR imaging in Lhermitte-Duclos disease: moving closer to pathology and pathophysiology.

B Thomas1, T Krishnamoorthy, V V Radhakrishnan, C Kesavadas.   

Abstract

INTRODUCTION: Lhermitte-Duclos disease (LDD, dysplastic gangliocytoma) is an extremely rare cerebellar lesion of uncertain etiology. The debate as to whether it constitutes a neoplastic, malformative, or hamartomatous lesion is still continuing. In this report we explore the usefulness of susceptibility-weighted imaging (SWI), diffusion weighted imaging (DWI), perfusion imaging, and chemical shift imaging (CSI) in demonstrating the pathology and pathophysiology in two patients with LDD.
METHODS: MR imaging of the brain and the cervicodorsal spine was performed on a 1.5-T scanner in a 47-year-old woman presenting with numbness and paresthesia of both upper and lower limbs, and in a 17-year-old male with right frontal headache associated with neck pain.
RESULTS: Routine imaging in the first patient showed a left-side cerebellar mass with characteristic 'tiger-striped' thick folia associated with Chiari I malformation, tonsillar herniation and cervicodorsal syringomyelia and in the second patient a right cerebellar mass with similar findings. The SWI demonstrated the characteristic deep running veins between the folia, which is thought to be the cause for vascular contrast enhancement. Diffusion showed a T2 shine-through effect with mild increased diffusivity, and perfusion showed increase in relative cerebral blood volume, relative cerebral blood flow, and mean transit time in the lesion. MR spectroscopy demonstrated reduction in metabolites and a prominent lactate peak in both the patients. The pathological and pathophysiological significance of these findings is discussed.
CONCLUSION: MRI with the newer imaging capabilities can demonstrate the pathology and pathophysiology in Lhermitte-Duclos disease better. SWI helps in detecting the veins around the thickened folia.

Entities:  

Mesh:

Year:  2007        PMID: 17549467     DOI: 10.1007/s00234-007-0241-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

1.  Lhermitte-Duclos disease: a tumour or not a tumour.

Authors:  P Demaerel; F Van Calenbergh; G Wilms
Journal:  Acta Neurol Scand       Date:  2003-10       Impact factor: 3.209

2.  Diffusion-weighted MRI in Lhermitte-Duclos disease: report of two cases.

Authors:  Gul Moonis; Mahanad Ibrahim; Elias R Melhem
Journal:  Neuroradiology       Date:  2004-04-16       Impact factor: 2.804

Review 3.  Clinical applications of neuroimaging with susceptibility-weighted imaging.

Authors:  Vivek Sehgal; Zachary Delproposto; E Mark Haacke; Karen A Tong; Nathaniel Wycliffe; Daniel K Kido; Yingbiao Xu; Jaladhar Neelavalli; Djamel Haddar; Jürgen R Reichenbach
Journal:  J Magn Reson Imaging       Date:  2005-10       Impact factor: 4.813

Review 4.  Recurrent Lhermitte-Duclos disease: report of two cases and association with Cowden's disease.

Authors:  D W Williams; A D Elster; L E Ginsberg; C Stanton
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jan-Feb       Impact factor: 3.825

5.  Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.

Authors:  Vivek Sehgal; Zachary Delproposto; Djamel Haddar; E Mark Haacke; Andrew E Sloan; Lucia J Zamorano; Geoffery Barger; Jiani Hu; Yingbiao Xu; Karthik Praveen Prabhakaran; Ilaya R Elangovan; Jaladhar Neelavalli; Jürgen R Reichenbach
Journal:  J Magn Reson Imaging       Date:  2006-07       Impact factor: 4.813

6.  Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement.

Authors:  E E Awwad; E Levy; D S Martin; G O Merenda
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

7.  MRI in Lhermitte-Duclos disease.

Authors:  K Kulkantrakorn; E E Awwad; B Levy; J B Selhorst; H O Cole; D Leake; J R Gussler; A D Epstein; M M Malik
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

Review 8.  Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature.

Authors:  Shenandoah Robinson; Alan R Cohen
Journal:  Neurosurg Focus       Date:  2006-01-15       Impact factor: 4.047

9.  Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy.

Authors:  J Klisch; F Juengling; J Spreer; D Koch; T Thiel; M Büchert; S Arnold; F Feuerhake; M Schumacher
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

10.  Brain PET and technetium-99m-ECD SPECT imaging in Lhermitte-Duclos disease.

Authors:  K Ogasawara; S Yasuda; T Beppu; M Kobayashi; M Doi; K Kuroda; A Ogawa
Journal:  Neuroradiology       Date:  2001-11       Impact factor: 2.804

View more
  12 in total

1.  A surgically treated case of Lhermitte-Duclos disease with a precise natural history and high uptake of FDG on PET.

Authors:  Yuko Goto; Naoya Hashimoto; Yoshiko Okita; Tetsu Goto; Carter Rabo; Hiroshi Hirayama; Yoshiharu Horikawa; Manabu Kinoshita; Naoki Kagawa; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2009-11-12       Impact factor: 4.130

2.  Lhermitte-Duclos disease. A case report.

Authors:  Andrea Giorgianni; Carlo Pellegrino; Alessandro De Benedictis; Anna Mercuri; Fabio Baruzzi; Renzo Minotto; Antonio Tabano; Sergio Balbi
Journal:  Neuroradiol J       Date:  2013-12-18

Review 3.  Update on neuroimaging phenotypes of mid-hindbrain malformations.

Authors:  Patrice Jissendi-Tchofo; Mariasavina Severino; Béatrice Nguema-Edzang; Cissé Toure; Gustavo Soto Ares; Anthony James Barkovich
Journal:  Neuroradiology       Date:  2014-10-23       Impact factor: 2.804

Review 4.  Postoperative cerebellar mutism in adult patients with Lhermitte-Duclos disease.

Authors:  Ali Afshar-Oromieh; Heinz Linhart; Dino Podlesek; Wiebke Schrempf; Gabriele Schackert; Dietmar Krex
Journal:  Neurosurg Rev       Date:  2010-07-29       Impact factor: 3.042

5.  Magnetic resonance characteristics of adult-onset Lhermitte-Duclos disease: An indicator for active cancer surveillance?

Authors:  Guangquan Wei; Wei Zhang; Qinlong Li; Xiaowei Kang; Haitao Zhao; Xianping Liu; Xing Tang; Yuanming Wu; Juntao Han; Hong Yin
Journal:  Mol Clin Oncol       Date:  2014-02-12

6.  Assessing a dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) with 7T MR imaging.

Authors:  Christoph Moenninghoff; Oliver Kraff; Marc Schlamann; Mark E Ladd; Zaza Katsarava; Elke R Gizewski
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

7.  Pseudotumoral hemicerebellitis as a mimicker of Lhermitte-Duclos disease in children: does neuroimaging help to differentiate them?

Authors:  Thangamadhan Bosemani; Maja Steinlin; Sandra P Toelle; Jürgen Beck; Eugen Boltshauser; Thierry A G M Huisman; Andrea Poretti
Journal:  Childs Nerv Syst       Date:  2015-12-09       Impact factor: 1.475

Review 8.  Similar MR imaging characteristics but different pathological changes: a misdiagnosis for Lhermitte-Duclos disease and review of the literature.

Authors:  Shengyue Huang; Guobin Zhang; Junting Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Increase in cerebellar volume in Cavalier King Charles Spaniels with Chiari-like malformation and its role in the development of syringomyelia.

Authors:  Thomas A Shaw; Imelda M McGonnell; Colin J Driver; Clare Rusbridge; Holger A Volk
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

10.  Neuroimaging abnormalities in patients with Cowden syndrome: Retrospective single-center study.

Authors:  Radhika Dhamija; Steven M Weindling; Alyx B Porter; Leland S Hu; Christopher P Wood; Joseph M Hoxworth
Journal:  Neurol Clin Pract       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.